Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Niepel

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
NPJ Systems Biology and Applications|April 18, 2017
L1000CDS<sup>2</sup>: LINCS L1000 characteristic direction signatures search engineQiaonan Duan, St Patrick Reid, Neil R Clark, et al.
The EMBO Journal|September 25, 2024
Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylationPulak Kar, Chatrin Chatrin, Nina Đukić, et al.
The EMBO Journal|June 4, 2024
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylationPulak Kar, Chatrin Chatrin, Nina Đukić, et al.
Cell Chemical Biology|July 18, 2020
In Vitro and Cellular Probes to Study PARP Enzyme Target EngagementTim J Wigle, Danielle J Blackwell, Laurie B Schenkel, et al.
Chemistry & Biology|January 31, 2012
Discovery of potent and selective covalent inhibitors of JNKTinghu Zhang, Francisco Inesta-Vaquera, Mario Niepel, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Nature Communications|September 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer modelsChun Wai Wong, Christos Evangelou, Kieran N Sefton, et al.
Cancer Research|February 26, 2013
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
NPJ Systems Biology and Applications|April 18, 2017
L1000CDS<sup>2</sup>: LINCS L1000 characteristic direction signatures search engineQiaonan Duan, St Patrick Reid, Neil R Clark, et al.
The EMBO Journal|September 25, 2024
Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylationPulak Kar, Chatrin Chatrin, Nina Đukić, et al.
The EMBO Journal|June 4, 2024
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylationPulak Kar, Chatrin Chatrin, Nina Đukić, et al.
Cell Chemical Biology|July 18, 2020
In Vitro and Cellular Probes to Study PARP Enzyme Target EngagementTim J Wigle, Danielle J Blackwell, Laurie B Schenkel, et al.
Chemistry & Biology|January 31, 2012
Discovery of potent and selective covalent inhibitors of JNKTinghu Zhang, Francisco Inesta-Vaquera, Mario Niepel, et al.
The Journal of Biological Chemistry|January 7, 2012
Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kineticsQingsong Liu, Sivapriya Kirubakaran, Wooyoung Hur, et al.
Chembiochem : a European Journal of Chemical Biology|April 10, 2021
Targeted Degradation of PARP14 Using a Heterobifunctional Small MoleculeTim J Wigle, Yue Ren, Jennifer R Molina, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Nature Communications|September 26, 2023
PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer modelsChun Wai Wong, Christos Evangelou, Kieran N Sefton, et al.
Cancer Research|February 26, 2013
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATRQingsong Liu, Chunxiao Xu, Sivapriya Kirubakaran, et al.
Pageof 5